The Five Pillars of the CELYFE Protocol
CELYFE Protocol Team
The CELYFE Protocol is built on the principle that NAD+ supplementation, while powerful, achieves its greatest potential when integrated with complementary lifestyle practices. Each pillar has been selected based on peer-reviewed evidence for its synergistic effect on NAD+ metabolism and cellular health.
PILLAR 1: SUPPLEMENTATION - The foundation. The CELYFE NAD+ Precision Pen delivers NAD+ directly via subcutaneous administration during the body's peak metabolic window (6:00-8:00 AM). This timing aligns with circadian NAD+ oscillations identified by Nakahata et al. in their research on CLOCK-SIRT1 interactions.
PILLAR 2: NUTRITION - Caloric restriction and time-restricted eating have been shown to activate AMPK and sirtuins, both of which support NAD+ biosynthesis. The protocol recommends a polyphenol-rich diet with omega-3 fatty acids, ketogenic cycling, and an eating window of 8-10 hours.
PILLAR 3: MOVEMENT - Zone 2 cardio (150min/week) and resistance training (3x/week) upregulate NAMPT expression, the rate-limiting enzyme in NAD+ production. VO2 max intervals and daily mobility work complete the movement framework.
PILLAR 4: COLD EXPOSURE - Deliberate cold exposure activates brown adipose tissue and SIRT3, a mitochondrial sirtuin dependent on NAD+. Protocols include cold showers (2-3 min), cold plunges (11°C/52°F for 1-3 min), or cryotherapy sessions.
PILLAR 5: SLEEP ARCHITECTURE - NAD+ levels follow circadian rhythms. Optimizing sleep through consistent wake times, light exposure management, and temperature regulation supports the natural NAD+ cycle. The protocol targets 7-9 hours with emphasis on deep sleep and REM quality.
Each pillar compounds with CELYFE supplementation. The protocol is designed as a systematic framework - not a rigid prescription - that adapts to individual lifestyles while maintaining the biological principles that drive cellular vitality.
*These products are food supplements and are not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated by the European Food Safety Authority (EFSA) or the U.S. Food and Drug Administration (FDA). Content is for informational purposes only and should not be considered medical advice.